...
首页> 外文期刊>Clinical and investigative medicine: Medecine clinique et experimentale >Relation of erythrocyte Na+-K+ ATPase activity and cholesterol and oxidative stress in patients with type 2 diabetes mellitus.
【24h】

Relation of erythrocyte Na+-K+ ATPase activity and cholesterol and oxidative stress in patients with type 2 diabetes mellitus.

机译:2型糖尿病患者红细胞Na + -K + ATPase活性与胆固醇和氧化应激的关系。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Diabetic patients are at high risk of atherosclerotic complications, and factors associated with this include hypercholesterolemia, hemorheologic disturbances in erythrocytes and oxidative stress. We, therefore, carried out a study in type 2 diabetic patients to determine the relationships of erythrocyte Na+-K+ ATPase activity, plasma cholesterol and oxidative stress in this population. METHODS: Erythrocyte Na+-K+ ATPase activity and its relationship between plasma cholesterol and thiobarbituric acid reactive substance (TBARS, a marker of oxidative stress) were studied in type 2 diabetic patients with (n = 26) or without angiopathy (n = 30). Na+-K+ ATPase activity was measured by a colorimetric enzymatic method. Plasma TBARS levels were determined spectrophotometrically. Diabetic patients were classified according to plasma cholesterol concentrations as normo- or hypercholesterolemic (plasma total cholesterol > 5.18 mmol/L). RESULTS: Diabetic patients with or without angiopathy had lower erythrocyte Na+-K+ ATPase activity (p < 0.001 and p < 0.001 respectively) and higher plasma TBARS levels than healthy subjects (n = 20) (p < 0.001 and p < 0.001 respectively). Na+-K+ ATPase activity in the diabetic patients with angiopathy was lower than in the diabetic patients without angiopathy (p < 0.001). In the diabetic patients both with and without angiopathy, hypercholesterolemic patients had lower erythrocyte Na+-K+ ATPase activity and higher plasma TBARS levels than normocholesterolemic patients (p < 0.001, p < 0.001 respectively) There was no difference in the plasma TBARS concentrations between diabetic patients with and without angiopathy. There were negative correlations between erythrocyte Na+-K+ ATPase activity and both plasma cholesterol (r = -0.72) and plasma TBARS (r = -0.46) and a positive correlation between plasma cholesterol and TBARS (r = 0.42). CONCLUSIONS: Elevated plasma cholesterol may be responsible for the inhibition of erythrocyte Na+-K+ ATPase activity. Together with elevated cholesterol, free radical-induced mechanisms may be involved in the inhibition of Na+-K+ ATPase activity.
机译:背景:糖尿病患者有动脉粥样硬化并发症的高风险,并且与之相关的因素包括高胆固醇血症,红细胞的血液流变学紊乱和氧化应激。因此,我们对2型糖尿病患者进行了一项研究,以确定该人群中红细胞Na + -K + ATPase活性,血浆胆固醇和氧化应激的关系。方法:研究了2型糖尿病患者(n = 26)或无血管病(n = 30)的红细胞Na +-K + ATPase活性及其与血浆胆固醇和硫代巴比妥酸反应性物质(TBARS,氧化应激的标志物)的关系。 Na + -K + ATPase活性通过比色酶法测定。分光光度法测定血浆TBARS水平。根据血浆胆固醇浓度将糖尿病患者分为正常胆固醇或高胆固醇血症(血浆总胆固醇> 5.18 mmol / L)。结果:有或无血管病的糖尿病患者的红细胞Na + -K + ATPase活性较低(分别为p <0.001和p <0.001)和血浆TBARS水平高于健康受试者(n = 20)(分别为p <0.001和p <0.001)。患有血管病的糖尿病患者的Na + -K + ATPase活性低于没有血管病的糖尿病患者(p <0.001)。在患有和不患有血管病的糖尿病患者中,高胆固醇血症患者的血红细胞Na + -K + ATPase活性和血浆TBARS水平均高于正常胆固醇血症患者(分别为p <0.001,p <0.001)。有无血管病。红细胞Na + -K + ATPase活性与血浆胆固醇(r = -0.72)和血浆TBARS(r = -0.46)之间呈负相关,而血浆胆固醇与TBARS之间(r = 0.42)呈正相关。结论:血浆胆固醇升高可能是抑制红细胞Na + -K + ATPase活性的原因。与胆固醇升高一起,自由基诱导的机制可能与Na + -K + ATPase活性的抑制有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号